Analyze Your Search


  • Action links for each search result record
    • Bookmark: Allows you to Bookmark the page for easy future retrieval 
    • Email: Opens a pop-up window where you can write a message to the recipient of the email
    • Copy URL: Copies the URL of the requested document for pasting in an email or other document
    • More Info: Shows full summary of content record
  • Saved Searches and Alerts
    • Save your search for later viewing & updates by clicking the blue "Follow" button to the right of the search box. 
  Follow Topic   Edit Search
Your search returned 19 results
from the time period: last 90 days.
Sort by Relevance / Date Group By Journal / No Grouping
It remains inconclusive whether Hashimoto's thyroiditis (HT) predisposes patients to the development of papillary thyroid carcinoma (PTC. We conducted a meta-analysis of the available data to address this question.Twenty-seven eligible studies were selected, including 18 archival thyroidectomy studies, 6 fine-needle aspiration (FNA) studies, and 3 selective FNA or thyroidectomy studies.
Oncology (1)
Thyroid Carcinoma (3), Thyroiditis (2), more mentions
Clinical endocrinology
Previous studies did not focus on the differences in the extent of cervical lymph node (LN) dissection according to coexistent Hashimoto's thyroiditis (HT) in patients with papillary thyroid carcinoma (PTC) and its clinical impact. We aimed to determine whether extensive cervical LN dissection is responsible for favorable clinical outcomes in PTC patients with HT and whether coexistence of HT itself ...
Oncology (2)
Thyroiditis (2), Thyroid Carcinoma (2), more mentions
The Lancet. Oncology
... died from non-treatment-related adverse events associated with death, and one patient died from treatment-related adverse events (myositis in addition to grade 3 thyroiditis, grade 3 hepatitis, grade 3 pneumonia, and grade 4 myocarditis) AbstractText: First-line pembrolizumab has antitumour activity and acceptable tolerability in cisplatin-ineligible patients with ...
Oncology (5), Infectious Diseases (1)
Neoplasms (6), Muscle Weakness (1), Colitis (1), more mentions
The Cochrane database of systematic reviews 
... serious adverse events such as hypercalcaemia (RR 5.00, 95% CI 0.25 to 100.8; 1 trial; 76 participants), myocardial infarction (RR 0.75, 95% CI 0.08 to 6.81; 2 trials; 86 participants), and thyroiditis (RR 0.33 95% CI 0.01 to 7.91; 1 trial; 68 participants) is uncertain because the results were imprecise.
Infectious Diseases (1)
Liver Diseases (5), Glossitis (1), Thyroiditis (1), more mentions
Clinical endocrinology
Univariant analysis indicated that capsular invasion, Hashimoto's thyroiditis, multifocal loci, central lymph node metastases as well as BRAF mutation predicted a high incidence ... This finding was associated with multifocal primary carcinomas involvement, capsular invasion, Hashimoto's thyroiditis history, central lymph node metastases and BRAF mutation, which should therefore be taken into consideration ...
Thyroid Carcinoma (4), Carcinoma (3), Thyroiditis (2), more mentions
AbstractText: There is a low risk of developing Graves disease (GD) with elevated thyrotropin receptor antibodies (TRAbs) in patients undergoing radioiodine therapy for toxic adenoma AbstractText: An old female patient with a history of Hashimoto thyroiditis was referred to our department due to thyrotoxic symptoms. After the administration of radioiodine, a significant remission was achieved.
Adenoma (5), Graves Disease (3), Thyrotoxicosis (2), more mentions
Melanoma research
Pituitary MRI showed an enlargement of the pituitary gland suggesting ACTH secretion of pituitary origin, which was confirmed by inferior petrosal sinus sampling. The pituitary findings were preceded by thyroiditis. The evolution was characterized by spontaneous CS regression and subsequent appearance of severe corticotroph deficiency consistent with destructive hypophysitis. Immunotherapy is a novel cause of CS.
Cushing Syndrome (2), Pituitary Neoplasms (1), Thyroiditis (1), more mentions
... leading to pathological activation or inhibition of complement with organ damage and/or limited capacity of the immune system to clear immune complexes and apoptotic debris. Finally, we summarize the role of complement antibodies in the pathogenesis of systemic lupus erythematosus and discuss the mechanism of some related clinical conditions such as infections, thyroiditis, thrombosis, acquired von Willebrand disease, etc.
Immune System Diseases (4)
Systemic Lupus Erythematosus (3), Thyroiditis (1), Type II Membranoproliferative Glomerulonephritis (1), more mentions
Stained cells were counted manually and analyzed for clinical and histopathologic correlations and disease-free survival AbstractText: Programmed cell death 1 ligand 1 expression was significantly correlated with increased incidence of lymphovascular invasion (P = .038), extrathyroidal extension (P = .026), and concurrent lymphocytic thyroiditis (P = .003. Patients with low CD8+ and CD3+ expression presented with a significantly higher incidence of lymph ...
Oncology (6)
Thyroid Carcinoma (4), Neoplasms (3), Autoimmune Thyroiditis (1), more mentions
... no space-occupying lesions, but heterogeneous enhancement of the pituitary gland AbstractText: Primary hypothyroidism and isolated ACTH deficiency. The etiologies were assumed to be nivolumab induced autoimmune lymphocytic thyroiditis and hypophysitis, respectively AbstractText: Hormone replacements with levothyroxine and acetate cortisone were given orally. Nivolumab was adjusted to lower dose and longer interval AbstractText: The patient felt good after adequate replacement.
Oncology (3), Immune System Diseases (2)
Hypothyroidism (4), Hypoglycemia (3), Carcinoma (2), more mentions
Preoperative PB TSHR mRNA expression levels were significantly associated with patient age, capsular invasion status, lymph node metastasis status, and BRAF(V600E) mutation status (P < 0.05) but not gender, tumor size, number of cancer foci, or Hashimoto thyroiditis status. Preoperative assessment of the PB TSHR mRNA expression level combined with ultrasonography of the thyroid had better accuracy in the diagnosis ...
Oncology (2)
Thyroid Carcinoma (3), Neoplasms (2), Hashimoto Disease (1), more mentions
Cancer immunology research
Our study demonstrates that most thyroid disorders induced by either anti-PD-1 or combination anti-PD-1 and anti-CTLA-4 therapy are thyroiditis. The time to onset of thyrotoxicosis after treatment initiation and evolution of thyrotoxicosis to hypothyroidism was short, emphasizing the importance of close monitoring of thyroid function in these patients.
Oncology (1)
Thyrotoxicosis (7), Hypothyroidism (5), Thyroiditis (1), more mentions
Journal of radiation research
Although it is difficult to draw a definitive conclusion, some data may suggest a transient effect of moderate- to low-dose irradiation on hypothyroidism and autoimmune thyroiditis, implying that the effect, if it exists, is reversible. Finally, no report has shown a statistically significant increase in the prevalence of moderate- to low-dose irradiation-induced Graves' hyperthyroidism Keyword: autoimmunity.
Oncology (1), Immune System Diseases (1)
Hyperthyroidism (5), Hypothyroidism (4), Autoimmune Thyroiditis (1), more mentions
Depression and anxiety
... well with clinical recommendations to routinely screen for thyroid disorders in patients with anxiety disorders, and with what is known from basic research about thyroid-brain interactions. The results of the risk of bias assessment underscore the importance of further high-quality experimental and longitudinal epidemiological research Keyword: Graves’ disease. Keyword: Hashimoto's thyroiditis. Keyword: anxiety. Keyword: hypothalamic-pituitary-thyroid axis.
Neuroscience (2), Anti-Obesity and Weight Loss (1)
Anxiety Disorders (5), Depressive Disorder (2), Panic Disorder (1), more mentions
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
As illustrated in this case series, in contrast to other causes of auto-immune thyroiditis, hypothyroidism can develop rapidly within 3 months of treatment. Close monitoring is necessary to detect the development of thyroid dysfunction and avoid preventable morbidity AbstractText: Anti-TPO Abs = anti-thyroglobulin antibodies; CT = computed tomography; CTLA-4 = cytotoxic T-lymphocyte-associated protein 4; FDA = U.S ...
Oncology (1)
Hypothyroidism (3), Hyperthyroidism (2), Thyroiditis (1), more mentions
Autoimmunity reviews
The rates of comorbidity in most studies were ≥1% for insulin-dependent diabetes mellitus, rheumatoid arthritis (RA), psoriasis and celiac disease (CD), ≥2% for Graves' disease, ≥3% for vitiligo, and ≥5% for pernicious anemia and Hashimoto's thyroiditis. Organ-specific AIDs are more prevalent in CSU than systemic (multiorgan or non organ-specific) AIDs.
Immune System Diseases (7), Blood Disorders and Hematology (2), Endocrine Disorders (1)
Urticaria (3), Vitiligo (2), Pernicious Anemia (2), more mentions
Thyroid : official journal of the American Thyroid Association
... care settings AbstractText: The cytopathologic results were classified according to the Bethesda System as non-diagnostic in 19%, cyst/cystic nodule in 21%, benign (including thyroiditis) in 48%, atypia of undetermined significance/follicular lesion of undetermined significance (AUS/FLUS) in 6%, follicular neoplasms/suspicious for follicular neoplasm (FN/SFN) in 4 ...
Oncology (2)
Thyroid Nodule (4), Neoplasms (3), Cysts (2), more mentions
PloS one
Possible associations of single-nucleotide polymorphisms (SNPs) of melatonin receptor type 1A (MTNR1A) and 1B (MTNR1B), with autoimmune thyroid disease in an ethnic Chinese (i.e., Taiwanese) population were examined AbstractText: Totally, 83 Hashimoto's thyroiditis patients, 319 Graves' disease (GD), and 369 controls were recruited. Three SNPs (rs6553010, rs13140012, and rs2119882) of MTNR1A and three SNPs (rs1387153, rs10830963, and rs1562444 ...
Immune System Diseases (2)
Graves Disease (3), Autoimmune Diseases (1), Thyroiditis (1), more mentions
Clinical endocrinology
BACKGROUND: Immunomodulatory therapies, including CTLA-4 and PD-1 inhibitors, provide a directed attack against cancer cells by preventing T cell deactivation. However, these drugs also prevent the down-regulation of auto-reactive T cells, resulting in immune-related adverse events (IRAEs). Reports show a varied incidence of endocrine IRAEs, ranging from 0-63%. OBJECTIVE: To describe the frequency and clinical characteristics of endocrine IRAEs in patients taking cancer immunomodulatory therapies. DESIGN: Retrospective cohort study. PATIENTS: 388 patients aged ≥18 years who were prescribed ipilimumab, nivolumab, and/or pembrolizumab between 2009-2016 at our institution. MEASUREMENTS: Biochemical criteria were used to define endocrine IRAEs, including thyroid, pituitary, pancreas, and adrenal dysfunction, following use of immunomodulatory therapies. RESULTS: 50 endocrine IRAEs occurred in our cohort, corresponding to a rate of 12.9%. The most common endocrine IRAEs were thyroid dysfunction (11.1%), with a lower incidence of pituitary dysfunction (1.8% of patients). CONCLUSIONS: Over 12% of patients receiving ipilimumab, nivolumab, and/or pembrolizumab in our study sample developed an endocrine IRAE. Patients who undergo treatment with immunomodulatory therapies should be monitored for the development of endocrine IRAEs. This article is protected by copyright. All rights reserved.
Oncology (3)
Neoplasms (3), more mentions